New and established technology in focal ablation of the prostate: a systematic review

M Valerio, Y Cerantola, SE Eggener, H Lepor… - European urology, 2017 - Elsevier
Context Focal therapy of prostate cancer has been proposed as an alternative to whole-
gland treatments. Objective To summarize the evidence regarding sources of energy …

[HTML][HTML] High intensity focused ultrasound: The fundamentals, clinical applications and research trends

IAS Elhelf, H Albahar, U Shah, A Oto… - Diagnostic and …, 2018 - Elsevier
Diagnostic ultrasound has been clinically used for decades. More recently, high intensity
focused ultrasound (HIFU) has been developed for therapeutic use as a non-invasive …

[HTML][HTML] A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer

S Guillaumier, M Peters, M Arya, N Afzal, S Charman… - European urology, 2018 - Elsevier
Background Clinically significant nonmetastatic prostate cancer (PCa) is currently treated
using whole-gland therapy. This approach is effective but can have urinary, sexual, and …

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3 …

AR Azzouzi, S Vincendeau, E Barret, A Cicco… - The Lancet …, 2017 - thelancet.com
Background Vascular-targeted photodynamic therapy, a novel tissue-preserving treatment
for low-risk prostate cancer, has shown favourable safety and efficacy results in single-arm …

Stimulated Raman scattering microscopy enables gleason scoring of prostate core needle biopsy by a convolutional neural network

J Ao, X Shao, Z Liu, Q Liu, J **a, Y Shi, L Qi, J Pan, M Ji - Cancer Research, 2023 - AACR
Focal therapy (FT) has been proposed as an approach to eradicate clinically significant
prostate cancer while preserving the normal surrounding tissues to minimize treatment …

[HTML][HTML] The role of focal therapy in the management of localised prostate cancer: a systematic review

M Valerio, HU Ahmed, M Emberton, N Lawrentschuk… - European urology, 2014 - Elsevier
Context The incidence of localised prostate cancer is increasing worldwide. In light of recent
evidence, current, radical, whole-gland treatments for organ-confined disease have being …

Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year …

D Reddy, M Peters, TT Shah, M van Son, MB Tanaka… - European Urology, 2022 - Elsevier
Background Focal therapy aims to treat areas of cancer to confer oncological control whilst
reducing treatment-related functional detriment. Objective To report oncological outcomes …

MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study

B Ehdaie, CM Tempany, F Holland, DD Sjoberg… - The Lancet …, 2022 - thelancet.com
Background Men with grade group 2 or 3 prostate cancer are often considered ineligible for
active surveillance; some patients with grade group 2 prostate cancer who are managed …

[HTML][HTML] IDEAL framework for surgical innovation 1: the idea and development stages

P McCulloch, JA Cook, DG Altman, C Heneghan… - Bmj, 2013 - bmj.com
IDEAL is a framework for evaluations of surgical innovations, which follow a distinct
development pathway differing from the approach developed for pharmacological …

Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient

OF Donati, Y Mazaheri, A Afaq, HA Vargas, J Zheng… - Radiology, 2014 - pubs.rsna.org
Purpose To evaluate the relationship between prostate cancer aggressiveness and
histogram-derived apparent diffusion coefficient (ADC) parameters obtained from whole …